626
19. O’Leary C, Wieneke P, Buckley S et al. Celiac disease and irritable
bowel-type symptoms. Am J Gastroenterol 2002; 97: 1463-
1467.
20. Dalrymple J, Bullock I. Diagnosis and management of irritable
bowel syndrome in adults in primary care: summary of NICE
guidance. BMJ 2008; 336: 556-558.
21. Troncone R, Greco L, Mayer M, et al. Latent and potential coeliac
disease. Acta Paediatr 1996; 412: 10-14.
22. Ludvigsson J, Leffler D, Bai C et al. The Oslo definitions for coeliac
disease and related terms. Gut 2013; 62: 43-52.
23. Volta U, Caio G, Stanghellini V, De Giorgio R. The changing clinical
profile of celiac disease: a 15-year experience (1998-2012) in an
Italian referral center. BMC Gastroenterol 2014; 14: 194-202.
24. Brar P, Kwon G, Egbuna I, et al. Lack of correlation of degree of
villous atrophy with severity of clinical presentation of coeliac
disease. Dig Liver Dis 2007; 39: 26-29.
25. Murray J, Rubio-Tapia A, Van Dyke C, et al. Mucosal atrophy in
celiac disease: extent of involvement, correlation with clinical
presentation, and response to treatment. Clin Gastroenterol
Hepatol 2008; 6: 186-193.
26. Matysiak-Budnik T, Malamut G, de Serre N, et al. Long-term
follow-up of 61 coeliac patients diagnosed in childhood:
evolution toward latency is possible on a normal diet. Gut 2007;
56; 1379-1386.
27. Rubio-Tapia A, Hill I, Kelly C, Calderwood A, Murray J. ACG Clinical
Guidelines: Diagnosis and Management of Celiac Disease. Am J
Gastroenterol 2013; 108: 656-676.
28. Ludvigsson J, Bai J, Biagi F, et al.Diagnosis and management
of adult coeliac disease: guidelines from de British Society of
Gastroenterology. 8, 2014, Gut, Vol. 63, págs. 1210-1228.
29. Bai J, FriedM, CorazzaG, et alWorldGastroenterologyOrganisation
Global Guidelines on Celiac Disease. J Clin Gastroenterol 2013;
47 (2): 121-126.
30. Czaja-Bulsa, G. Non coeliac gluten sensitivity. Clinical nutrition
2014, en prensa.
doi.org/10.1016/j.clnu.2014.08.012.31. Leffler DA, Schuppan D. Update on serologic testing in celiac
disease. Am J Gastroenterol 2010; 105: 2520-2524.
32. McGowan K, Lyon M, Butzner J. Celiac disease and IgA deficiency:
complications of serological testing approaches encountered in
the clinic. Clin Chem 2008; 54: 1203-1209.
33. Oxentenko A, Murray J. Celiac Disease: Ten Things That Every
Gastroenterologist Should Know. Clin Gastroenterol Hepatol
2014, en prensa. doi: 10.1016/j.cgh.2014.07.024.
34. Oxentenko A, Grisolano S, Murray J, Burgart L, Dierkhising R,
Alexander J. The insensitivity of endoscopic markers in celiac
disease. Am J Gastroenterol 2002; 97: 933-938.
35. Gasbarrini A, Ojetti V, Cuoco L, et al. Lack of endoscopic
visualization of intestinal villi with the “immersion technique”
in overt atrophic celiac disease. Gastrointest Endosc 2003; 57:
348-351.
36. Siegel L, Stevens P, Lightdale C, et al. Combined magnification
endoscopy with chromoendoscopy in the evaluation of patients
with suspected malabsorption. Gastrointest Endosc 1997; 46:
226-230.
37. Kurien M, Evans K, Hopper A, Hale M, Cross S, Sanders D.
Duodenal bulb biopsies for diagnosing adult celiac disease: is
there an optimal biopsy site?. Gastrointestinal Endoscopy 2012;
75: 1190-1196.
38. Atlas D, Rubio-Tapia A , Van Dyke C, et al. Capsule endoscopy
in nonresponsive celiac disease. Gastrointest Endosc 2011; 74:
1315-1322.
39. Kav T, Sivri B. Is enteroscopy necessary for diagnosis of celiac
disease? World J Gastroenterol 2012; 18: 4095-4101.
40. Oberhuber, G. Histopathology of celiac disease. Biomed
Pharmacother 2000; 54: 368-372.
41. Corazza G, Villanacci V, Zambelli C, et al. Comparison of the
interobserver reproducibility with different histologic criteria
used in celiac disease. Clin Gastroenterol Hepatol 2007; 5:
838-843.
42. Guandalini S, Ventura A , Ansaldi N, et al. Diagnosis of coeliac
disease: time for a change? Arch Dis Child 1989; 64: 1320-
1324.
43. Husby S, Koletzko S , Korponay-Szabo I, et al. European Society for
Pediatric Gastroenterology, Hepatology, and Nutrition guidelines
for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr
2012; 54: 136-160.
44. Walker M, Murray J, Ronkainen J, et al. Detection of celiac
disease and lymphocytic enteropathy by parallel serology and
histopathology in a population-based study. Gastroenterology
2010; 139: 112-119.
45. Aziz I, Evans K, Hopper A, Smillie D, Sanders D. A prospective study
into the aetiology of lymphocytic duodenosis. Aliment Pharmacol
Ther 2010; 32: 1392-1397.
46. Beltran L, Koenig M, Egner W, et al. High-titre circulating tissue
transglutaminase-2 antibodies predict small bowel villous
atrophy, but decision cut-off limits must be locally validated.
Exp Immunol 2014; 176: 190-198.
47. Mubarak A, Wolters V, Gmelig-Meyling F, Ten Kate F, Houwen
R. Tissue transglutaminase levels above 100 U/mL and celiac
disease: a prospective study. World J Gastroenterol 2012; 18:
4399-4403.
48. Araya M, Oyarzun A, Lucero Y, Espinosa N, Perez-Bravo F. DQ2,
DQ7 and DQ8 Distribution and Clinical Manifestations in Celiac
Cases and Their First-Degree Relatives. Nutrients 2015; 7:
4955-4965.
49. Wouters J, Weijerman M, van Furth A, et al. Prospective human
leukocyte antigen, endomysium immunoglobulin A antibodies,
and transglutaminase antibodies testing for celiac disease in
children with Down syndrome. J Pediatr 2009; 154: 239-242.
50. Akobeng AK, Thomas AG. Systematic review: tolerable amount of
gluten for people with coeliac disease. Aliment Pharmacol Ther
2008; 27 (11): 1044-1052.
51. Hall N, Rubin G, Charnock A. Systematic review: adherence to a
gluten-free diet in adult patients with coeliac disease. Aliment
Pharmacol Ther 2009; 30: 315-330.
52. Aziz I, Evans K, Papageorgiou V, et al. Are patients whit coeliac
disease seeking alternative therapies to gluten-free diet?
Gastrointestin Liver Dis 2011; 20: 27-31.
[REV. MED. CLIN. CONDES - 2015; 26(5) 613-627]